162 related articles for article (PubMed ID: 8400231)
1. Elevated platelet count as a cause of abnormal von Willebrand factor multimer distribution in plasma.
Budde U; Scharf RE; Franke P; Hartmann-Budde K; Dent J; Ruggeri ZM
Blood; 1993 Sep; 82(6):1749-57. PubMed ID: 8400231
[TBL] [Abstract][Full Text] [Related]
2. Acquired von Willebrand disease in patients with high platelet counts.
Budde U; van Genderen PJ
Semin Thromb Hemost; 1997; 23(5):425-31. PubMed ID: 9387201
[TBL] [Abstract][Full Text] [Related]
3. The reduction of large von Willebrand factor multimers in plasma in essential thrombocythaemia is related to the platelet count.
van Genderen PJ; Budde U; Michiels JJ; van Strik R; van Vliet HH
Br J Haematol; 1996 Jun; 93(4):962-5. PubMed ID: 8703834
[TBL] [Abstract][Full Text] [Related]
4. Abnormalities of von Willebrand factor in myeloproliferative disease: a relationship with bleeding diathesis.
Fabris F; Casonato A; Grazia del Ben M; De Marco L; Girolami A
Br J Haematol; 1986 May; 63(1):75-83. PubMed ID: 3085704
[TBL] [Abstract][Full Text] [Related]
5. Multimeric composition of plasma von Willebrand factor in chronic myeloproliferative disorders.
Tatewaki W; Takahashi H; Shibata A
Clin Lab Haematol; 1988; 10(4):417-25. PubMed ID: 3150698
[TBL] [Abstract][Full Text] [Related]
6. Subunit composition of plasma von Willebrand factor in patients with the myeloproliferative syndrome.
Budde U; Dent JA; Berkowitz SD; Ruggeri ZM; Zimmerman TS
Blood; 1986 Dec; 68(6):1213-7. PubMed ID: 3535924
[TBL] [Abstract][Full Text] [Related]
7. Qualitative and quantitative modifications of von Willebrand factor in patients with essential thrombocythemia and controlled platelet count.
Lancellotti S; Dragani A; Ranalli P; Petrucci G; Basso M; Tartaglione R; Rocca B; De Cristofaro R
J Thromb Haemost; 2015 Jul; 13(7):1226-37. PubMed ID: 25876231
[TBL] [Abstract][Full Text] [Related]
8. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.
Michiels JJ; Berneman Z; Schroyens W; Finazzi G; Budde U; van Vliet HH
Semin Thromb Hemost; 2006 Sep; 32(6):589-604. PubMed ID: 16977569
[TBL] [Abstract][Full Text] [Related]
9. Bleeding signs due to acquired von Willebrand syndrome at diagnosis of chronic myeloid leukaemia in children.
Knöfler R; Lange BS; Paul F; Tiebel O; Suttorp M
Br J Haematol; 2020 Mar; 188(5):701-706. PubMed ID: 31617211
[TBL] [Abstract][Full Text] [Related]
10. Decreased half-life time of plasma von Willebrand factor collagen binding activity in essential thrombocythaemia: normalization after cytoreduction of the increased platelet count.
van Genderen PJ; Prins FJ; Lucas IS; van de Moesdijk D; van Vliet HH; van Strik R; Michiels JJ
Br J Haematol; 1997 Dec; 99(4):832-6. PubMed ID: 9432029
[TBL] [Abstract][Full Text] [Related]
11. Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes.
Villmow T; Kemkes-Matthes B; Matzdorff AC
Thromb Res; 2002 Nov; 108(2-3):139-45. PubMed ID: 12590950
[TBL] [Abstract][Full Text] [Related]
12. Acquired von Willebrand disease in myeloproliferative disorders.
van Genderen PJ; Leenknegt H; Michiels JJ; Budde U
Leuk Lymphoma; 1996 Sep; 22 Suppl 1():79-82. PubMed ID: 8951776
[TBL] [Abstract][Full Text] [Related]
13. A new congenital platelet abnormality characterized by spontaneous platelet aggregation, enhanced von Willebrand factor platelet interaction, and the presence of all von Willebrand factor multimers in plasma.
Casonato A; De Marco L; Mazzucato M; De Angelis V; De Roia D; Fabris F; Ruggeri ZM; Girolami A
Blood; 1989 Nov; 74(6):2028-33. PubMed ID: 2804346
[TBL] [Abstract][Full Text] [Related]
14. Platelet von Willebrand factor abnormalities in myeloproliferative syndromes.
Castaman G; Lattuada A; Ruggeri M; Tosetto A; Mannucci PM; Rodeghiero F
Am J Hematol; 1995 Aug; 49(4):289-93. PubMed ID: 7639273
[TBL] [Abstract][Full Text] [Related]
15. A new von Willebrand variant (type I, New York): increased ristocetin-induced platelet aggregation and plasma von Willebrand factor containing the full range of multimers.
Weiss HJ; Sussman II
Blood; 1986 Jul; 68(1):149-56. PubMed ID: 3487353
[TBL] [Abstract][Full Text] [Related]
16. A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers.
Casonato A; Pontara E; Dannhäuser D; Bertomoro A; Sartori MT; Girolami A
Haematologia (Budap); 1994; 26(2):97-109. PubMed ID: 7890268
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte proteases do not process endothelial cell-derived unusually large von Willebrand factor multimers to plasma vWF in vivo.
Phillips MD; Vu C; Nolasco L; Moake JL
Am J Hematol; 1991 Jun; 37(2):80-3. PubMed ID: 2069167
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia and altered platelet behavior influence von Willebrand factor multimeric composition in secondary pulmonary hypertension.
Caramurú LH; Soares Rde P; Maeda NY; Lopes AA
Clin Appl Thromb Hemost; 2003 Jul; 9(3):251-8. PubMed ID: 14507115
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of different diagnostic tools for detection of acquired von Willebrand syndrome in patients with polycythemia vera or essential thrombocythemia.
Janjetovic S; Rolling CC; Budde U; Schneppenhem S; Schafhausen P; Peters MC; Bokemeyer C; Holstein K; Langer F
Thromb Res; 2022 Oct; 218():35-43. PubMed ID: 35988442
[TBL] [Abstract][Full Text] [Related]
20. Multimeric composition of plasma von Willebrand factor in chronic myelocytic leukaemia.
Tatewaki W; Takahashi H; Hanano M; Shibata A
Thromb Res; 1988 Oct; 52(1):23-32. PubMed ID: 3264424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
